US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives.
Saved in:
| Title: | US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives. |
|---|---|
| Authors: | Evans, Jeff |
| Source: | Pediatric News. Aug2024, p1-2. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179579620 AccessLevel: 2 PubType: News PubTypeId: newspaperArticle PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Evans%2C+Jeff%22">Evans, Jeff</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Pediatric+News%22">Pediatric News</searchLink>. Aug2024, p1-2. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179579620 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: 1 Titles: – TitleFull: US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Evans, Jeff IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: Aug2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 0031398X Titles: – TitleFull: Pediatric News Type: main |
| ResultId | 1 |